CXCR2 and infection: In this study, we investigated the impact of a CXCR4 antagonist on the pathogenic phenotypes seen in patients with chronic neutropenia, including abnormalities in blood and BM neutrophil levels, as well as infection susceptibility, in a pharmacologically induced CXCR2 LOF mouse model.